Publications by authors named "Pierre Arvis"

Claim this Profile
L
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.
Shivaani Kummar, Lin Shen, David S Hong, Ray McDermott, Vicki L Keedy, Pierre Arvis

Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Larotrectinib versus historical standard of care in patients with infantile fibrosarcoma: protocol of EPI-VITRAKVI.
Matthieu Carton, Johanna Peña Del Castillo, Jean-Baptiste Colin, Milena Kurtinecz, Marion Feuilly, Pierre Arvis

Future Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital tool to identify and monitor regorafenib-associated hand-foot skin reactions: A proof-of-concept study protocol.
Romain Coriat, Vincent Sibaud, Vincent Bourgeois, Sylvain Manfredi, Pascal Artru, Pierre Arvis

Dig Liver Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.
Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Daniel Haverstock

Int J Chron Obstruct Pulmon Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of moxifloxacin in hospitalized patients with secondary peritonitis: pooled analysis of four randomized phase III trials.
Jan J De Waele, Jose M Tellado, Günter Weiss, Jeffrey Alder, Frank Kruesmann, Pierre Arvis

Surg Infect (Larchmt)· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of patients receiving moxifloxacin for acute bacterial rhinosinusitis in clinical practice: results from an international, observational cohort study.
Ralph Mösges, Martin Desrosiers, Pierre Arvis, Stephanie Heldner

PLoS One· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moxifloxacin in complicated skin and skin structure infections (cSSSIs): A prospective, international, non-interventional, observational study.
Johannes R Bogner, Ammar Kutaiman, Melanie Esguerra-Alcalen, Stephanie Heldner, Pierre Arvis

Adv Ther· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A role for TLR1, TLR2 and NOD2 in cytokine induction by Bacteroides fragilis.
Mark H T Stappers, Nico A F Janssen, Marije Oosting, Theo S Plantinga, Pierre Arvis

Cytokine· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.
Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Jeff Alder

Eur Respir J· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis.
Marc Miravitlles, Frank Kruesmann, Daniel Haverstock, Renee Perroncel, Shurjeel H Choudhri, Pierre Arvis

Eur Respir J· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moxifloxacin safety: an analysis of 14 years of clinical data.
Paul M Tulkens, Pierre Arvis, Frank Kruesmann

Drugs R D· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the cardiac safety of moxifloxacin.
Wilhelm Haverkamp, Frank Kruesmann, Anna Fritsch, David van Veenhuyzen, Pierre Arvis

Curr Drug Saf· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.
Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Geneviève Faragó

Int J Chron Obstruct Pulmon Dis· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.
Inge C Gyssens, Matthew Dryden, Peter Kujath, Dilip Nathwani, Nicolaas Schaper, Pierre Arvis

J Antimicrob Chemother· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
Antoni Torres, Javier Garau, Pierre Arvis, Jean Carlet, Shurjeel Choudhri

Clin Infect Dis· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia.
Nicolas Simon, Emmanuelle Sampol, Jacques Albanese, Claude Martin, Pierre Arvis

Clin Pharmacol Ther· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors.
Stéphane Bronner, François Jehl, Jean-Daniel Peter, Marie-Cécile Ploy, Corinne Renault, Pierre Arvis

Antimicrob Agents Chemother· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
Ralf Siegert, Olof Berg, Pierre Gehanno, Alberto Leiberman, Jonas Laimutis Martinkenas, Pierre Arvis

Eur Arch Otorhinolaryngol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis